Short answer
Procter & Gamble (PG) filed its Q4 2025 10-Q quarterly report on Jan 23, 2026 for the quarter ended Dec 31, 2025. Quarterly revenue was $22.2B (up 1.5% year over year) with net income of $4.3B.
Q4 2025 key financials · XBRL
- Revenue
- $22.2B
- +1.5% YoY · −0.8% QoQ
- Net income
- $4.3B
- −6.7% YoY · −9.1% QoQ
- Operating margin
- 24.2%
- EPS (diluted)
- $1.78
- −5.3% YoY · −8.7% QoQ
Source: XBRL data from the Procter & Gamble (PG) Q4 2025 10-Q on SEC EDGAR. USD.
Procter & Gamble Q4 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue $22.2B, up 1% YoY from $21.9B; organic sales flat excluding acquisitions/divestitures and FX
- Operating margin 24.2% vs 26.2% YoY; net earnings margin 19.4% vs 21.2%; net earnings down 7% to $4.3B; diluted EPS $1.78 vs $1.88 (-5%)
- Best segment: Beauty sales up 5% ($4.0B); worst: Baby, Feminine & Family Care sales down 3% ($5.1B) and net earnings down 9% ($1.0B)
- Operating cash flow $10.4B YTD, adjusted free cash flow $8.7B, free cash flow productivity 95%; CapEx $2.4B contributing to $2.8B investing cash outflow
- Management expects $1.5-$2.0B restructuring costs over 2 years; notes risks from FX volatility, tariffs, competitive pressures, and macro uncertainties impacting near-term results
Risk Factors
- No new or changed risk factors reported this quarter versus the fiscal 2025 10-K
- Continuing supply chain disruptions risk impacting raw material availability and production costs
- Ongoing compliance risk with global regulations on product safety and sustainability standards
- Intense competitive pressure from private label brands affecting market share and pricing power
- Currency exchange rate volatility risk, especially exposure to euro and emerging market currencies
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Procter & Gamble quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.